Tandem Diabetes Care (TNDM) Shareholder's Equity (2013 - 2026)
Tandem Diabetes Care (TNDM) Shareholder's Equity (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 13.34 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Tandem Diabetes Care | 1.04 Bn | 474.17 Mn | 136.79 Mn | 132.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.40 Mn |
| Dec 31, 2025 | 155.17 Mn |
| Sep 30, 2025 | 132.97 Mn |
| Jun 30, 2025 | 133.28 Mn |
| Mar 31, 2025 | 155.29 Mn |
| Dec 31, 2024 | 263.10 Mn |
| Sep 30, 2024 | 237.71 Mn |
| Jun 30, 2024 | 233.88 Mn |
| Mar 31, 2024 | 243.06 Mn |
| Dec 31, 2023 | 313.63 Mn |
| Sep 30, 2023 | 314.00 Mn |
| Jun 30, 2023 | 329.23 Mn |
| Mar 31, 2023 | 338.75 Mn |
| Dec 31, 2022 | 439.95 Mn |
| Sep 30, 2022 | 421.82 Mn |
| Jun 30, 2022 | 449.58 Mn |
| Mar 31, 2022 | 437.38 Mn |
| Dec 31, 2021 | 433.11 Mn |
| Sep 30, 2021 | 389.65 Mn |
| Jun 30, 2021 | 346.09 Mn |